PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response

被引:422
|
作者
Zhang, Feng [2 ]
Ma, Jianglin [1 ]
Wu, Jiaxue [2 ]
Ye, Lin [2 ]
Cai, Hong [1 ]
Xia, Bing [1 ]
Yu, Xiaochun [2 ]
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Radiat Oncol, Canc Inst New Jersey, New Brunswick, NJ 08903 USA
[2] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
FANCONI-ANEMIA; CANCER SUSCEPTIBILITY; S-PHASE; PHOSPHORYLATION; ATM; BACH1; RECOMBINATION; CHECKPOINT; PARTNER; PROTEIN;
D O I
10.1016/j.cub.2009.02.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BRCA1 and BRCA2 are often mutated in familial breast and ovarian cancer. Both tumor suppressors play key roles in the DNA-damage response [1, 2]. However, it remains unclear whether these two tumor suppressor function together in the same DNA-damage response pathway. Here, we show that BRCA1 associates with BRCA2 through PALB2/FANCN, a major binding partner of BRCA2 [3]. The interaction between BRCA1 and BRCA2 is abrogated in PAL132-deficient Fanconi anemia cells and in the cells depleted of PALB2 by small interfering RNA. Moreover, we show that BRCA1 promotes the concentration of PALB2 and BRCA2 at DNA-damage sites and the interaction between BRCA1 and PALB2 is important for the homologous recombination repair. Taken together, our results indicate that BRCA1 is an upstream regulator of BRCA2 in the DNA-damage response, and PALB2 is the linker between BRCA1 BRCA2.
引用
收藏
页码:524 / 529
页数:6
相关论文
共 50 条
  • [41] Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals
    Kuusisto, Kirsi M.
    Bebel, Aleksandra
    Vihinen, Mauno
    Schleutker, Johanna
    Sallinen, Satu-Leena
    BREAST CANCER RESEARCH, 2011, 13 (01):
  • [42] BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
    Maxwell, Kara N.
    Wubbenhorst, Bradley
    Wenz, Brandon M.
    De Sloover, Daniel
    Pluta, John
    Emery, Lyndsey
    Barrett, Amanda
    Kraya, Adam A.
    Anastopoulos, Ioannis N.
    Yu, Shun
    Jiang, Yuchao
    Chen, Hao
    Zhang, Nancy R.
    Hackman, Nicole
    D'Andrea, Kurt
    Daber, Robert
    Morrissette, Jennifer J. D.
    Mitra, Nandita
    Feldman, Michael
    Domchek, Susan M.
    Nathanson, Katherine L.
    NATURE COMMUNICATIONS, 2017, 8
  • [43] Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and P53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers
    Tair Kontorovich
    Yoram Cohen
    Uri Nir
    Eitan Friedman
    Breast Cancer Research and Treatment, 2009, 116 : 195 - 200
  • [44] BRCA1 16 years later: DNA damage-induced BRCA1 shuttling
    Yang, Eddy S.
    Xia, Fen
    FEBS JOURNAL, 2010, 277 (15) : 3079 - 3085
  • [45] Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and P53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers
    Kontorovich, Tair
    Cohen, Yoram
    Nir, Uri
    Friedman, Eitan
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (01) : 195 - 200
  • [46] Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families
    Garcia, Maria J.
    Fernandez, Victoria
    Osorio, Ana
    Barroso, Alicia
    LLort, Gemma
    Lazaro, Conxi
    Blanco, Ignacio
    Caldes, Trinidad
    de la Hoya, Miguel
    Ramon y Cajal, Teresa
    Alonso, Carmen
    Tejada, Maria-Isabel
    San Roman, Carlos
    Robles-Diaz, Luis
    Urioste, Miguel
    Benitez, Javier
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 113 (03) : 545 - 551
  • [47] Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links
    Rickman, Kimberly A.
    Noonan, Raymond J.
    Lach, Francis P.
    Sridhar, Sunandini
    Wang, Anderson T.
    Abhyankar, Avinash
    Huang, Athena
    Kelly, Michael
    Auerbach, Arleen D.
    Smogorzewska, Agata
    GENES & DEVELOPMENT, 2020, 34 (11-12) : 832 - 846
  • [48] The Role of PALB2 in the DNA Damage Response and Cancer Predisposition
    Nepomuceno, Thales C.
    De Gregoriis, Giuliana
    Bastos de Oliveira, Francisco M.
    Suarez-Kurtz, Guilherme
    Monteiro, Alvaro N.
    Carvalho, Marcelo A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (09)
  • [49] Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms
    Schulz, Eduard
    Valentin, Angelika
    Ulz, Peter
    Beham-Schmid, Christine
    Lind, Karin
    Rupp, Verena
    Lackner, Herwig
    Woelfler, Albert
    Zebisch, Armin
    Olipitz, Werner
    Geigl, Jochen
    Berghold, Andrea
    Speicher, Michael R.
    Sill, Heinz
    JOURNAL OF MEDICAL GENETICS, 2012, 49 (07) : 422 - 428
  • [50] BRCA2 is epistatic to the RAD51 paralogs in response to DNA damage
    Jensen, Ryan B.
    Ozes, Ali
    Kim, Taeho
    Estep, Allison
    Kowalczykowski, Stephen C.
    DNA REPAIR, 2013, 12 (04) : 306 - 311